Cancer oriented biobanks: A comprehensive review
Biobanks provide a platform for innovative biomedical research and has improvised translational and personalized medicine to a great extent. Time 2009 published 10 ideas changing the world right now with biobanks on the list emphasizing its role in discovery and development of new therapeutic drugs. They form the cornerstone, providing resources for future investigations and biomarker discovery to understand the effects of genetic, environmental and lifestyle factors on human morbidity, mortality and health. The aim of this review paper is to understand the role of biobanking in cancer research, the challenges faced and strategies to overcome these, for long term and sustainable research in the field of oncology.
Ma X, Yu H. Global burden of cancer. Yale J Biol Med 2006;79:85-94.
Kinkorova J. Biobanks in the era of personalized medicine: objectives, challenges, and innovation. EPMAJ 2015;7:4.
Luo J, Guo XR, Tang XJ, Sun XY, Yang ZS, Zhang Y. Intravital biobank and personalized cancer therapy: the correlation with omics. Int J Cancer 2014;135: 1511-1516.
Capocasa M, Anagnostou P, Abramo F, Matteucci G, Dominici V, Bisol GD. Samples and data accessibility in research biobanks: an explorative survey. Peer J 2016;4:e1613.
Braun KL, Tsark JU, Powers A, Croom K, Kim R, Gachupin FC. Cancer patient perceptions about biobanking and preferred timing of consent. Biopreserv Biobank 2014;12:106-112.
Grizzle WE, Bell WC, Sexton KC. Issues in collecting, processing and storing human tissues and associated information to support biomedical research. Cancer Biomark 2010;9:531-549
Astrin JJ, Zhou X, Misof B. The impotance of biobanking in molecular taxonomy, with proposed definitions for vouchers in a molecular context. Zookeys 2013;365:67-70.
Shokralla S, Gibson JF, Nikbakht H, Janzen DH, Hallwachs W, Hajibabaei M. Next-generation DNA barcoding: using next-generation sequencing to enhance and accelerate DNA barcode capture from single specimens. Mol Ecol Resour 2014;14:892-901.
Swede H, Stone CL, Norwood AR. National population-based biobanks for genetic research. Genetics in Medicine 2007;9:141-149.
Jafari S, Abdollahi M, Saeidnia S. Personalized medicine: a confluence of traditional and contemporary medicine. Altern Ther Health Med 2014;20(5):31-40.
Hood L, Friend SH. Predictive, personalized, preventive, participatory (P4) cancer medicine.Nature Reviews Clinical Oncology 2011;8:184-187.
Chalmers D, Nicol D, Kaye J, Bell J, Campbell AV, Ho CW. Has the biobank bubble burst? Withstanding the challenges for sustainable biobanking in the digital era. BMC Med Ethics 2016;17:39.
Ragin C, Park JY. Biospecimens, biobanking and global cancer research collaborations. Ecancermedicalscience 2014; 8: 454.
Donald SA. Principles of research tissue banking and specimen evaluation from the pathologist's perspective.Biopreserv Biobank 2010; 8:197–201.
Gee S, Oliver R, Corfield J, Georghiou L, Yuille M. Biobank Finances: A Socio-Economic Analysis and Review. Biopreserv Biobank 2015;13:435-451.
Rahm AK, Wrenn M, Caroll NM, Feigelson HS. Biobanking for research: a survey of patient population attitudes and understanding. J Community Genet 2013;4:445-450.
Sarojini S, Goy A, Pecora A, Suh KS. Proactive Biobanking to Improve Research and Health Care. J Tissue Sci Eng 2012; 3:116.
Budimir D, Polasek O, Marusić A, Kolcić I, Zemunik T, Boraska V. Ethical aspects of human biobanks: a systematic review. Croat Med J 2011; 52(3): 262–279.
Hansson MG. Ehics and biobanks. Br J Cancer 2009;100:8-12.
Zika E, Schulte In den Bäumen T, Kaye J, Brand A, Ibarreta D. Sample, data use and protection in biobanking in Europe: legal issues. Pharmacogenomics 2008;9:773-81.
Hallinan D, Friedewald M. Open consent, biobanking and data protection law: can open consent be 'informed' under the forthcoming data protection regulation? Life Sci Soc Policy 2015;11:1.
Blais CA, Patenaude J. A biobank management model applicable to biomedical research. BMC Medical Ethics 2006;7:4.
Vaught J, Kelly A, Hewitt R. A Review of International Biobanks and Networks: Success Factors and Key Benchmarks. Biopreserv Biobank 2009;7(3): 143–150.
NCRI Confederation of Cancer Biobanks (Available from http:// www.ccb.ncri.org.uk)
Texas cancer research biobank (Available from http:// www. http://txcrb.org/)
Victorian cancer biobank (Available from http://www.viccancerbiobank.org.au/)
Wales cancer bank (Available from http://www.walescancerbank.com/)
Alberta cancer research biobank (Available from http://www.acrb.ca/)
Cancer Research UK Manchester Institute (Available from http://www.cruk.manchester.ac.uk/)
Umass memorial health care- cancer center of excellence (Available from http://www.umassmed.edu/ccoe/core-services/tissue-and-tumor-bank/)
Cancer Research UK Leicester Centre (Available from http://www2.le.ac.uk/partnership/lcrc)
The Australasian Biospecimen Network (ABN) (Available from http://abrn.net/)
National Cancer Tissue Biobank (NCTB) (Available from https://nctb.iitm.ac.in/)
IARC - International Agency for Research on Cancer (Available from https://www.iarc.fr/)
Sturgeon C, Hill R, Hortin GL, Thompson D. Taking a new biomarker into routine use – A perspective from the routine clinical biochemistry laboratory. Proteomics Clin Appl 2010;4: 892–903.
Ardini MA, Pan H, Qin Y, Cooley PC. Sample and data sharing: Observations from a central data repository. Clin Biochem 2014;47:252-7.
Thomsen C, Sebbag R, Knoppers BM. Trends in ethical and legal frameworks for the use of human biobanks. Eur Respir J 2007;30: 373-382.
Vora T, Thacker N. Impacts of a biobank: Bridging the gap in translational cancer medicine. Indian J Med Paediatr Oncol 2015;36:17-23.
De Souza YG, Greenspan JS. Biobanking Past, Present and Future: Responsibilities and Benefits. AIDS 2013; 27: 303–312.
Grüner N, Stambouli O, Ross RS. Dried Blood Spots - preparing and processing for use in immunoassays and in molecular techniques. J Vis Exp 2015;97:e52619.
Dash RC, Robb JA, Booker DL, Foo WC, Witte DL, Bry L. Biospecimens and biorepositories for the community pathologist. Arch Pathol Lab Med 2012;136(6): 668–678.
Grizzle WE, Gunter EW, Sexton KC, Bell WC. Quality Management of Biorepositories. Biopreserv Biobank 2015; 13(3):183–194.
Pelagio G, Pistillo D, Mottolese M. Minimum biobanking requirements: issues in a comprehensive cancer center biobank. Biopreserv Biobank 2011;9(2):141-8.
Certified repository technician training program (available from www.isber.org/page/CRT/Certified-Repository-Technician-Training-Program.htm)
Shabihkhani M, Lucey GM, Wei B, Mareninov S, Lou JJ, Vinters HV et al. The procurement, storage, and quality assurance of frozen blood and tissue biospecimens in pathology, biorepository, and biobank settings. Clin Biochem 2014;47(0):258–266.
Mendy M , Caboux E, Sylla BS, Dillner J, Chinquee J, Wild C. Infrastructure and facilities for human biobanking in low- and middle-income countries: A situation analysis. Pathobiology 2014;81:252–260.
PlumX Metrics provide insights into the ways people interact with individual pieces of research output (articles, conference proceedings, book chapters, and many more) in the online environment. Examples include, when research is mentioned in the news or is tweeted about. Collectively known as PlumX Metrics, these metrics are divided into five categories to help make sense of the huge amounts of data involved and to enable analysis by comparing like with like.
Copyright (c) 2018 Shankargouda Patil, Barnali Majumdar, Kamran Habib Awan, Gargi S. Sarode, Sachin C. Sarode, Amol R. Gadbail, Shailesh Gondivkar
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.